Synergistic enhancement by 12-O-tetradecanoylphorbol-13-acetate and dibutyryl cAMP of 1 alpha,25-dihydroxyvitamin D-3 action in human promyelocytic leukemic HL-60 cells
Y. Hiura et al., Synergistic enhancement by 12-O-tetradecanoylphorbol-13-acetate and dibutyryl cAMP of 1 alpha,25-dihydroxyvitamin D-3 action in human promyelocytic leukemic HL-60 cells, ENDOCR J, 46(2), 1999, pp. 317-324
We have reported that dibutyryl cAMP (dbcAMP), an activator of cAMP-depende
nt protein kinase (PKA), potentiated the effects of 1 alpha,25-dihydroxyvit
amin D-3(1,25-(OH)(2)D-3)-induced 24-hydroxylation activity in HL-60 cells
by increasing 1,25-(OH)(2)D-3 receptor (VDR). The present study demonstrate
d that 12-O-tetradecanoylphorbol-13-acetate (TPA), a potent phorbol ester,
also potentiated the effect of 1,25-(OH)(2)D-3 on HL-60 cells and that TPA
and dbcAMP acted in a synergistic manner to enhance the effect of 1,25-(OH)
(2)D-3. It is interesting that TPA induced 24-hydroxylation activity far mo
re efficiently than dbcAMP, in addition to their effects in increasing VDR.
TPA increased basal levels of c-fos mRNA to the maximum by 1 h after the t
reatment, whereas dbcAMP failed to affect c-fos gene expression. Together w
ith the previous data indicating the presence of AP-1-like sequence in the
promoter of 24-hydroxylase gene, it was suggested that TPA potentiated the
effect of 1,25-(OH)(2)D-3 through an activation of c-fos gene expression. T
his notion was further supported by the data showing that TPA and dbcAMP al
so acted in a synergistic manner to activate c-fos gene expression, Neither
TPA nor dbcAMP affected c-jun early response gene in the HL-60 clone used
in the present study.
The present study suggested that the activation of early c-fos response gen
e by TPA might be another mechanism to enhance the effect of 1,25-(OH)(2)D-
3, besides up-regulation of VDR.